MTEMQ — Molecular Templates Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$9.66m
- $57.31m
Annual income statement for Molecular Templates, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 22.3 | 18.8 | 38.7 | 19.8 | 57.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 92.7 | 121 | 119 | 109 | 66 |
| Operating Profit | -70.4 | -102 | -80.1 | -88.9 | -8.67 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -69.4 | -105 | -83 | -92.7 | -8.13 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -69.4 | -105 | -83 | -92.7 | -8.12 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -69.4 | -105 | -83 | -92.7 | -8.12 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -69.4 | -105 | -83 | -92.7 | -8.12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -18.8 | -32.4 | -22.5 | -24.6 | -2 |